Live news related to UCB stock (BE0003739530): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
UCB and Biogen announced on Monday the publication in The Lancet of the phase 3 results of dapirolizumab pegol (DZP) in the treatment of systemic lupu…
UCB announced on Tuesday data from the BE BOLD trial confirming the clinical superiority of Bimzelx (bimekizumab) over Skyrizi (risankizumab) in the t…
UCB SA has announced the convening of its ordinary and extraordinary general meeting on April 30, 2026. The pharmaceutical group will submit for share…
TD Cowen établit une recommandation à l'achat sur UCB et relève son objectif de cours à 310 €.
Morgan Stanley revoit à la baisse sa position sur le titre UCB ce vendredi 6 mars 2026.
TD Cowen ajuste sa recommandation sur le titre UCB ce vendredi.
Wolfe Research établit une recommandation de surperformance sur UCB ce mardi 24 février 2026.
UBS ajuste ce jeudi sa position sur le titre UCB.
This Thursday, UCB stock marked a new historical high at 287 euros on Euronext Brussels, surpassing the previous peak of 286.40 euros reached the day …
Rothschild & Co Redburn établit une recommandation d'achat sur UCB.
